Joseph H. French
Yeshiva University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joseph H. French.
Neuropsychologia | 1986
Charles Miezejeski; Edmund C. Jenkins; A.Lewis Hill; Krystyna E. Wisniewski; Joseph H. French; W. Ted Brown
Fragile X, a recently discovered X-linked syndrome, is usually associated with mental retardation in affected males. Less consistent findings have been described for females. neuropsychological evaluation of seven nonretarded females from fragile X families suggested a characteristic profile: on Wechsler IQ tests, a positive Verbal-Performance score difference and lower subtest scaled scores on Arithmetic, Digit Span, Block Design, and Object Assembly; on the Wide Range Achievement Test, a lower score on Arithmetic than on Reading or Spelling; and on the Benton Visual Retention Test, defective recall. These results suggest the existence of X-linked learning disability in females.
Journal of Computer Assisted Tomography | 1979
Eric J. Russell; Robert D. Zimmerman; Norman E. Leeds; Joseph H. French
Four patients with well documented Reye syndrome were examined with noncontrast computed tomography. Acute findings are those of diffuse cerebral edema with low density in deep white matter, increased gray-white matter differentiation, and evidence of secondary ventricular compression. The diffuse nature of the changes is unlike the more focal pattern often seen in true viral encephalitis. Residual changes after severe diseases are those of nonspecific cerebral degeneration and are most pronounced in the frontal lobes. Atrophic ventricular dilatation was observed in two cases. Computed tomography findings correlate with all known pathologic studies and with the subsequent clinical courses in the patients examined.
Biochemical Medicine | 1984
Fred J. Kieras; George E. Houck; Joseph H. French; Krystyna E. Wisniewski
Glycosaminoglycans (GAGs) were prepared from the urine of three patients and from normal individuals by cetylpyridinium chloride precipitation and Pronase digestion. The GAGs were analyzed by electrophoresis, anion-exchange chromatography, and enzymatic and chemical degradation. Each of the three patients showed a four- to fivefold increase in urinary GAG excretion compared to normal controls and in one patient a tenfold increase was measured during a period of behavioral agitation which included joint swelling. Urinary GAGs from affected individuals were characterized by a high proportion of low sulfated molecules. The predominant low sulfated component was chondroitin-4-sulfate (C4S); however, small amounts of chondroitin-6-sulfate (C6S) were also present. Heparan sulfate (HS) was present in normal proportion (5-10%) and most of it was not low sulfated. Abnormal excretion of chondroitin (Ch), hyaluronic acid (HA), and dermatan sulfate (DS) was not detected. These findings suggest that the clinical manifestations of Lowe syndrome may be caused by a defect in GAG metabolism.
JAMA Neurology | 1972
Joseph H. French; Earl S. Sherard; Harry Lubell; Miriam Brotz; Cyril L. Moore
Pediatrics | 1975
Gerald S. Golden; Joseph H. French
JAMA Neurology | 1972
Nitya R. Ghatak; Asao Hirano; Tung P. Poon; Joseph H. French
JAMA Neurology | 1977
Asao Hirano; Josefina F. Llena; Joseph H. French; Nitya R. Ghatak
Journal of Neurology, Neurosurgery, and Psychiatry | 1972
Gerald S. Golden; Nitya R. Ghatak; Asao Hirano; Joseph H. French
Annals of Neurology | 1979
Makoto Iwata; Asao Hirano; Joseph H. French
JAMA Neurology | 1975
A. James Rowan; C. E. Pippenger; Peter McGregor; Joseph H. French